Search Count: 9
 |
Complex Of Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) And Z1834339853
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-06-26 Classification: TRANSPORT PROTEIN Ligands: MG, ATP, POV, ZRH |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2024-06-26
Ligands: MG, ATP, POV, ZRH
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-07-05 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U0R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-07-05
Ligands: U0R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TKX |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TKX
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TNI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TNI
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1J |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1J
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U26 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U26
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2B |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2B
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2I |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2I